Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: an individually controlled cohort study.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  European Journal of Medical Research

• Publication date

  2001-09-28

• Fields of study

  Medicine

• Identifiers
  PMID 11669085
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunopathology of hepatitis C

  2004cited by this paper
• Depression, fatigue, and functional disability in patients with chronic hepatitis C.

  2000cited by this paper
• Hypereosinophilia Induced by High-Dose Intratumoral and Peritumoral Mistletoe Application to a Patient with Pancreatic Carcinoma

  2000cited by this paper
• [Placebo effects and adverse effects in clinical trials].

  2000cited by this paper
• Musculoskeletal pain and fatigue are associated with chronic hepatitis C: a report of 239 hepatology clinic patients.

  1999cited by this paper
• Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals.

  1999cited by this paper
• Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C.

  1999cited by this paper
• Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection.

  1999cited by this paper
• Thionins from Viscum album L: influence of the viscotoxins on the activation of granulocytes.

  1999cited by this paper
• Flow cytometric analyses of the specific activation of peripheral blood mononuclear cells from healthy donors after in vitro stimulation with a fermented mistletoe extract and mistletoe lectins.

  1998cited by this paper
• Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract.

  1998cited by this paper
• Detection of type 2‐like T‐helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity

  1997cited by this paper
• The role of immune responses in the pathogenesis of hepatitis C virus infection

  1997cited by this paper
• Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection.

  1997cited by this paper
• Oligoclonal in vitro response of CD4 T cells to vesicles of mistletoe extracts in mistletoe-treated cancer patients

  1997cited by this paper
• Treatment of advanced pancreatic cancer with mistletoe: results of a pilot trial.

  1996cited by this paper
• Immune responses in hepatitis C virus infection.

  1996cited by this paper
• [Effect of mistletoe lectin therapy on serum level of defined serum proteins (acute phase proteins) in tumor patients].

  1993cited by this paper
• Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up.

  1992cited by this paper
• [An allergy to mistletoe extract].

  1991cited by this paper
• Demonstration of specifically sensitized lymphocytes in patients treated with an aqueous mistletoe extract (Viscum album L.)

  1991cited by this paper
• Increased secretion of tumor necrosis factors alpha, interleukin 1, and interleukin 6 by human mononuclear cells exposed to beta-galactoside-specific lectin from clinically applied mistletoe extract.

  1990cited by this paper
• Anti-mistletoe lectin antibodies are produced in patients during therapy with an aqueous mistletoe extract derived fromViscum album L. and neutralize lectin-induced cytotoxicity in vitro

  1990cited by this paper
• Influence of Viscum album preparations on the natural killer cell-mediated cytotoxicity of peripheral blood

  1989cited by this paper
• Mistletoe lectins and their A and B chains.

  1986cited by this paper

• Phytonutrient Profiles of Mistletoe and Their Values and Potential Applications in Ethnopharmacology and Nutraceuticals: A Review

  2025cites this paper
• Biological activity of mistletoe: in vitro and in vivo studies and mechanisms of action

  2020cites this paper
• Mistletoe extract Fraxini inhibits the proliferation of liver cancer by down-regulating c-Myc expression

  2019cites this paper
• [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection].

  2018cites this paper
• Misteltherapie bei chronischen viralen Infekten

  2013cites this paper
• Anthroposophic Medicine: An Integrative Medical System Originating in Europe

  2013cites this paper
• Klinische Forschung zur Anthroposophischen Medizin – Update eines «Health Technology Assessment»-Berichts und Status Quo

  2011cites this paper
• In vitro Immunoreactivity towards Lectin-rich or Viscotoxin-rich Mistletoe (Viscum album L.) Extracts Iscador Applied to Healthy Individuals

  2006cites this paper
• Exploratory Study on the Effects of Treatment with Two Mistletoe Preparations on Chronic Hepatitis C

  2005cites this paper
• Mistletoe treatment induces GM-CSF- and IL-5 production by PBMC and increases blood granulocyte- and eosinophil counts: a placebo controlled randomized study in healthy subjects.

  2005cites this paper
• Alternative Therapiestrategien chronischer Virushepatitiden

  2002cites this paper